D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1426
Definium Therapeutics
DFTX
$4.79B
| $14.8M | 0.01% |
315,410
+43,693
| +16% | +$1.08M |
2025 Q1
5 quarters
|
|
1427
Prestige Consumer Healthcare
PBH
$2.26B
| $14.8M | 0.01% |
313,778
-67,255
| -18% | -$3.46M |
2018 Q4
30 quarters
|
|
1428
Bicara Therapeutics
BCAX
$1.13B
| $14.8M | 0.01% |
498,193
+221,250
| +80% | +$4.94M |
2025 Q4
2 quarters
|
|
1429
Chubb
CB
$137B
| $14.8M | 0.01% |
43,383
+37,394
| +624% | +$12.2M |
2021 Q4
18 quarters
|
|
1430
PUT
Humana
HUM
$50.7B
| $14.8M | 0.01% |
37,200
-62,700
| -63% | -$17.9M |
2023 Q4
10 quarters
|
|
1431
Star Bulk Carriers
SBLK
$3.36B
| $14.8M | 0.01% |
591,314
-582,563
| -50% | -$15.1M |
2025 Q4
2 quarters
|
|
1432
UGI
UGI
$8.26B
| $14.7M | 0.01% |
426,188
-81,945
| -16% | -$2.9M |
2026 Q1
1 quarter
|
|
1433
CALL
Dave Inc
DAVE
$4.52B
| $14.7M | 0.01% |
39,500
+29,300
| +287% | +$7.62M |
2025 Q2
4 quarters
|
|
1434
PUT
KKR & Co
KKR
$82B
| $14.7M | 0.01% |
160,100
+117,600
| +277% | +$11.4M |
2024 Q3
7 quarters
|
|
1435
Antero Midstream
AM
$9.9B
| $14.7M | 0.01% |
644,890
+230,024
| +55% | +$5M |
2021 Q4
18 quarters
|
|
1436
Burford Capital
BUR
$738M
| $14.7M | 0.01% |
3,577,247
+2,609,417
| +270% | +$11.9M |
2025 Q4
2 quarters
|
|
1437
Westlake Corp
WLK
$8.25B
| $14.6M | 0.01% |
200,534
-32,649
| -14% | -$3.19M |
2024 Q3
7 quarters
|
|
1438
Nutanix
NTNX
$19.1B
| $14.6M | 0.01% |
286,917
+259,283
| +938% | +$11.7M |
2021 Q1
21 quarters
|
|
1439
Lamar Advertising Co
LAMR
$15.7B
| $14.6M | 0.01% |
93,715
+86,285
| +1,161% | +$12.5M |
2024 Q4
6 quarters
|
|
1440
Idea Acquisition Corp
IACO
$438M
| $14.6M | 0.01% |
+1,472,601
| New | +$14.5M |
2026 Q2
0 quarters
|
|
1441
Orion
OEC
$308M
| $14.5M | 0.01% |
2,194,308
-282,485
| -11% | -$2.03M |
2022 Q4
14 quarters
|
|
1442
Affiliated Managers Group
AMG
$9.9B
| $14.5M | 0.01% |
42,839
+3,578
| +9% | +$1.11M |
2016 Q2
40 quarters
|
|
1443
Wheaton Precious Metals
WPM
$54.9B
| $14.5M | 0.01% |
129,019
+115,767
| +874% | +$15.1M |
2024 Q3
7 quarters
|
|
1444
Hello Group
MOMO
$646M
| $14.5M | 0.01% |
2,496,180
-79,829
| -3% | -$476K |
2024 Q3
7 quarters
|
|
1445
Colgate-Palmolive
CL
$75B
| $14.5M | 0.01% |
157,872
-321,478
| -67% | -$28.1M |
2014 Q3
47 quarters
|
|
1446
ANI Pharmaceuticals
ANIP
$1.67B
| $14.5M | 0.01% |
174,732
-38,701
| -18% | -$3.1M |
2024 Q2
8 quarters
|
|
|
BCAR
1447
DELISTED
D. Boral ARC Acquisition I Corp
BCAR
| $14.5M | 0.01% |
1,385,950
| – | – |
2025 Q3
3 quarters
|
|
1448
Assured Guaranty
AGO
$3.05B
| $14.4M | 0.01% |
180,107
+48,148
| +36% | +$3.8M |
2022 Q1
17 quarters
|
|
1449
Church & Dwight Co
CHD
$25B
| $14.4M | 0.01% |
148,791
-611,921
| -80% | -$58.5M |
2020 Q4
22 quarters
|
|
1450
CALL
eToro Group
ETOR
$1.9B
| $14.4M | 0.01% |
365,200
+130,200
| +55% | +$4.9M |
2026 Q1
1 quarter
|
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.